KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Land & Improvements (2016 - 2024)

Historic Land & Improvements for Eli Lilly (LLY) over the last 14 years, with Q4 2024 value amounting to $382.0 million.

  • Eli Lilly's Land & Improvements rose 1944.97% to $382.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $382.0 million, marking a year-over-year increase of 1944.97%. This contributed to the annual value of $382.0 million for FY2024, which is 1944.97% up from last year.
  • As of Q4 2024, Eli Lilly's Land & Improvements stood at $382.0 million, which was up 1944.97% from $319.8 million recorded in Q4 2023.
  • In the past 5 years, Eli Lilly's Land & Improvements registered a high of $382.0 million during Q4 2024, and its lowest value of $226.8 million during Q4 2020.
  • Over the past 5 years, Eli Lilly's median Land & Improvements value was $258.7 million (recorded in 2021), while the average stood at $288.8 million.
  • Per our database at Business Quant, Eli Lilly's Land & Improvements soared by 3380.53% in 2020 and then tumbled by 81.18% in 2022.
  • Over the past 5 years, Eli Lilly's Land & Improvements (Quarter) stood at $226.8 million in 2020, then rose by 14.07% to $258.7 million in 2021, then fell by 0.81% to $256.6 million in 2022, then rose by 24.63% to $319.8 million in 2023, then rose by 19.45% to $382.0 million in 2024.
  • Its last three reported values are $382.0 million in Q4 2024, $319.8 million for Q4 2023, and $256.6 million during Q4 2022.